Comment on “Evaluation of Antiviral Therapy Performed after Curative Therapy in Patients with HBV-Related Hepatocellular Carcinoma: An Updated Meta-Analysis”

Comment on “Evaluation of Antiviral Therapy Performed after Curative Therapy in Patients with HBV-Related Hepatocellular Carcinoma: An Updated Meta-Analysis”

Saved in:

Bibliographic Details
Main Authors:	Han-Yue Mo, Bang-De Xiang, Jian-Hong Zhong, Le-Qun Li, Xue-Mei You
Format:	Article
Language:	English
Published:	Wiley 2016-01-01
Series:	Canadian Journal of Gastroenterology and Hepatology
Online Access:	http://dx.doi.org/10.1155/2016/7625982
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Evaluation of Antiviral Therapy Performed after Curative Therapy in Patients with HBV-Related Hepatocellular Carcinoma: An Updated Meta-Analysis
by: Peng Yuan, et al.
Published: (2016-01-01)

The Role of Antiviral Therapy for HBV-Related Hepatocellular Carcinoma
by: Liang-He Yu, et al.
Published: (2011-01-01)

Antiviral therapy can effectively suppress irAEs in HBV positive hepatocellular carcinoma treated with ICIs: validation based on multi machine learning
by: Shuxian Pan, et al.
Published: (2025-01-01)

Targeting immune checkpoints in hepatocellular carcinoma therapy: toward combination strategies with curative potential
by: Jing Tong, et al.
Published: (2025-05-01)

Development of a Nomogram for Prognostic Prediction of Large Hepatocellular Carcinoma With HBV After TACE Combined Conversion Therapy
by: Xu W, et al.
Published: (2025-04-01)

T cell receptor repertoire profiling predicts the prognosis of HBV‐associated hepatocellular carcinoma
by: Kai‐Rong Lin, et al.
Published: (2018-08-01)

Efficacy of Transarterial Chemoembolisation with or without Antiviral Therapy for Patients with Hepatocellular Carcinoma after Radical Hepatectomy
by: Yin Zhu, et al.
Published: (2018-01-01)

Impact of viral eradication by direct-acting antivirals on clinical outcomes after curative treatment for hepatitis C virus-associated hepatocellular carcinoma
by: Yuko Nagaoki, et al.
Published: (2025-03-01)

High Prevalence of Preexisting HBV Polymerase Mutations in Pregnant Women Does Not Limit the Antiviral Therapy Efficacy
by: Jing Wang, et al.
Published: (2021-01-01)

Stratified aspartate aminotransferase-to-platelet ratio index accurately predicts survival in hepatocellular carcinoma patients undergoing curative liver resection
by: Hao-Jie Yang, et al.
Published: (2017-03-01)

Pre- and postoperative predictors of extrahepatic recurrence after curative resection for hepatocellular carcinoma
by: Chang Hun Lee, et al.
Published: (2025-08-01)

Prediction Model for Familial Aggregated HBV‐Associated Hepatocellular Carcinoma Based on Serum Biomarkers
by: Linmei Zhong, et al.
Published: (2025-06-01)

Prognostic value of neutrophil-to-lymphocyte ratio in patients with hepatocellular carcinoma receiving curative therapies: a systematic review and meta-analysis
by: Jinxiang Peng, et al.
Published: (2025-03-01)

Hepatocellular Carcinoma in Delta Hepatitis Versus HBV Monoinfection: Spot the Differences
by: Razvan Cerban, et al.
Published: (2025-05-01)

Halting hepatocellular carcinoma: Identifying intercellular crosstalk in HBV-driven disease
by: Lingyun Zhou, et al.
Published: (2025-04-01)

Sorafenib-treated hepatocellular carcinoma with or without prior direct-acting antiviral therapy for hepatitis C: outcomes and survival
by: Rania Lithy, et al.
Published: (2025-08-01)

Direct-acting antiviral therapy for patients with hepatitis C virus-related hepatocellular carcinoma: A nationwide cohort study
by: Shou-Wu Lee, et al.
Published: (2025-07-01)

Risk factors of early recurrence after curative hepatectomy in hepatocellular carcinoma
by: Young Mi Hong, et al.
Published: (2017-10-01)

Preoperative platelet-to-lymphocyte ratio is a valuable prognostic biomarker in patients with hepatocellular carcinoma undergoing curative liver resection
by: Hao-Jie Yang, et al.
Published: (2017-06-01)

Glucocorticoids and antivirals for HBV reactivation in onco-hematologic patients
by: Michela di Fonzo, et al.
Published: (2010-02-01)

Glucocorticoids and antivirals for HBV reactivation in onco-hematologic patients
by: Alfredo Marzano, et al.
Published: (2010-12-01)

Association between HLA-DQ Gene Polymorphisms and HBV-Related Hepatocellular Carcinoma
by: Jingzhu Lv, et al.
Published: (2017-01-01)

Successful antiviral therapy for chronic hepatitis C in a patient after surgery for hepatocellular carcinoma (a clinical observation)
by: I. G. Nikitin, et al.
Published: (2018-08-01)

Serum LncRNAs Profiles Serve as Novel Potential Biomarkers for the Diagnosis of HBV-Positive Hepatocellular Carcinoma.
by: Kang Wang, et al.
Published: (2015-01-01)

Viral-Track integrated single-cell RNA-sequencing reveals HBV lymphotropism and immunosuppressive microenvironment in HBV-associated hepatocellular carcinoma
by: Zhepeng Liu, et al.
Published: (2025-07-01)

Prognostic significance of early and multiple recurrences after curative resection for hepatocellular carcinoma
by: Akihiro Tanemura, et al.
Published: (2024-10-01)

Advances in neoadjuvant therapy for hepatocellular carcinoma
by: Dongming Liu, et al.
Published: (2025-06-01)

Stereotactic body radiation therapy in hepatocellular carcinoma
by: Gagan Saini
Published: (2020-01-01)

Postoperative hepatitis B virus reactivation and its impact on survival in HBV-related hepatocellular carcinoma patients undergoing conversion therapy with interventional therapy combined with tyrosine kinase inhibitors and immune checkpoint inhibitors
by: Shaowei Xu, et al.
Published: (2025-07-01)

Evaluation of serum ESPL1 as a biomarker for early diagnosis of HBV-related hepatocellular carcinoma
by: Lu-Huai Feng, et al.
Published: (2025-04-01)

HBV sequence integrated to enhancer acting as oncogenic driver epigenetically promotes hepatocellular carcinoma development
by: Lu Chen, et al.
Published: (2025-05-01)

MACHINE LEARNING-BASED CLASSIFICATION OF HBV AND HCV-RELATED HEPATOCELLULAR CARCINOMA USING GENOMIC BIOMARKERS
by: Sami Akbulut, et al.
Published: (2022-10-01)

Relationship between HBsAg/HBV DNA and prognosis in patients with HBV-related hepatocellular carcinoma treated with PD-1/PD-L1 inhibitors
by: Qiuying Qin, et al.
Published: (2025-06-01)

Prognosis in the Early Stages of Hepatocellular Carcinoma: Predicting Outcomes and Properly Selecting Patients for Curative Options
by: Kelly W Burak
Published: (2011-01-01)

Integrating bulk and single cell sequencing data to identify prognostic biomarkers and drug candidates in HBV associated hepatocellular carcinoma
by: Yanjie Zhong, et al.
Published: (2025-07-01)

Virological response and predictive factors for antiviral treatment in chronic HBV-related liver disease with low ALT and high HBV DNA
by: Lei Ma, et al.
Published: (2025-02-01)

The role of immune regulation in HBV infection and hepatocellular carcinogenesis
by: Hailong Zheng, et al.
Published: (2025-03-01)

Identifying key genes involved in HBV-related hepatocellular carcinoma: diagnose, prognosis, interaction and immune analysis
by: Yan Li, et al.
Published: (2025-08-01)

HBV DNA integration gene CCDC91 is oncogenic and a potential therapeutic target for hepatocellular carcinoma
by: Mengge Li, et al.
Published: (2025-07-01)

Treatment Outcomes of Systemic Therapies for Infiltrative Hepatocellular Carcinoma
by: Chen PY, et al.
Published: (2025-06-01)